Recalls / Active ingredient / Olopatadine Hydrochloride
Olopatadine Hydrochloride
2 FDA drug recalls involving the active ingredient “Olopatadine Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-09-24 | Class II | Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metere | Glenmark Pharmaceuticals Inc., USA |
| 2022-06-29 | Class II | Pataday, Once Daily Relief, Olopatadine hydrochloride ophthalmic solution 0.2%, Antihistamine, Eye Allergy Itc | Mckesson Medical-Surgical Inc. Corporate Office |